• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Peripheral arthritis in family practice].

作者信息

de Bock G H

机构信息

Vakgroeup Huisartsgeneeskunde, Rijksuniversiteit Leiden.

出版信息

Tijdschr Gerontol Geriatr. 1996 Apr;27(2):67-72.

PMID:8669074
Abstract

Osteoarthritis is a common disease of the cartilage in a joint for which the general practitioner (GP) is frequently consulted. In this contribution the current policy of GPs is described with respect to patients with peripheral osteoarthritis. For this purpose, the medical records of 196 patients from 14 Dutch general practitioners were studied with regard to the GPs management, and the GPs were interviewed about their management. Also, the burden of osteoarthritis was assessed in terms of quality of life for 198 patients. Moreover, the effects of two nonsteroidal treatments (nabumetone versus piroxicam) were studied in 198 patients. GPs management is heterogeneous. The results of the interviews supported this finding. The quality of life of patients with osteoarthritis was significantly reduced in several areas of daily living. After treatment with nonsteroidals the patients' status improved, according to both the GPs and the patients. The GPs and the patients' perspective on change correlated weakly. In future research, it would be interesting to explore these two perspectives.

摘要

相似文献

1
[Peripheral arthritis in family practice].
Tijdschr Gerontol Geriatr. 1996 Apr;27(2):67-72.
2
Randomized double-blind study of nabumetone and piroxicam in the treatment of osteoarthritis in Dutch general practice: efficacy and tolerability.
Pharm World Sci. 1993 Jun 18;15(3):132-8. doi: 10.1007/BF02113942.
3
Health-related quality of life assessments in osteoarthritis during NSAID treatment.
Pharm World Sci. 1996 Aug;18(4):130-6. doi: 10.1007/BF00717728.
4
Nabumetone compared with indomethacin in the treatment of osteoarthritis in general practice.萘丁美酮与吲哚美辛在全科医疗中治疗骨关节炎的比较。
J Rheumatol Suppl. 1992 Nov;36:58-62.
5
Clinical efficacy and safety of nabumetone in rheumatoid arthritis and osteoarthritis.
J Rheumatol Suppl. 1992 Nov;36:32-40.
6
Nabumetone therapy of osteoarthritis. A six-week, placebo-controlled study.
Am J Med. 1987 Oct 30;83(4B):70-3. doi: 10.1016/0002-9343(87)90598-5.
7
[Beta-cyclodextrin-piroxicam in the treatment of the active phase of osteoarthritic pathology].β-环糊精-吡罗昔康治疗骨关节炎病理活动期
Riv Eur Sci Med Farmacol. 1990 Aug-Oct;12(4-5):265-72.
8
Clinical, double-blind long-term study of tenoxicam 20 mg (Ro 12-0068) versus piroxicam 20 mg in patients with gonarthrosis.替诺昔康20毫克(Ro 12 - 0068)与吡罗昔康20毫克治疗膝骨关节炎患者的临床双盲长期研究
Eur J Rheumatol Inflamm. 1987;9(2):74-6.
9
A 6-month, double-blind study comparing nabumetone to naproxen in the treatment of osteoarthritis.一项为期6个月的双盲研究,比较萘丁美酮与萘普生治疗骨关节炎的效果。
Pharmatherapeutica. 1987;5(2):90-8.
10
Nabumetone versus naproxen in the treatment of osteoarthritis. A six-month trial.萘丁美酮与萘普生治疗骨关节炎的六个月试验。
Am J Med. 1987 Oct 30;83(4B):82-5. doi: 10.1016/0002-9343(87)90601-2.